
1. malar j. 2016 nov 8;15(1):540.

plasmodium vivax multidrug resistance-1 gene polymorphism french guiana.

faway e(1)(2), musset l(1)(3)(4), pelleau s(1)(3)(4), volney b(1)(3)(4), casteras
j(1)(3), caro v(5), menard d(6)(7), briolant s(1)(8)(9), legrand
e(10)(11)(12)(13)(14).

author information: 
(1)laboratoire de parasitologie, institut pasteur de la guyane, cayenne, french
guiana.
(2)urphym-narilis, university namur, namur, belgium.
(3)national reference center malaria, institut pasteur de la guyane, cayenne,
french guiana.
(4)world health organization collaborating center surveillance of
antimalarial drug resistance, institut pasteur de la guyane, cayenne, french
guiana.
(5)environment infectious risks unit, genotyping pathogens pole, institut 
pasteur, paris, france.
(6)malaria molecular epidemiology unit, institut pasteur cambodia, phnom penh,
cambodia.
(7)malaria translational research unit, institut pasteur cambodia, phnom penh,
cambodia.
(8)direction interarmées du service de santé, cayenne, french guiana.
(9)institut de recherche biomédicale des armées, brétigny sur orge, france.
(10)laboratoire de parasitologie, institut pasteur de la guyane, cayenne, french 
guiana. eric.legrand@pasteur.fr.
(11)national reference center malaria, institut pasteur de la guyane,
cayenne, french guiana. eric.legrand@pasteur.fr.
(12)world health organization collaborating center surveillance of
antimalarial drug resistance, institut pasteur de la guyane, cayenne, french
guiana. eric.legrand@pasteur.fr.
(13)malaria translational research unit, institut pasteur, paris, france.
eric.legrand@pasteur.fr.
(14)genetics genomics insect vectors unit, institut pasteur, paris,
france. eric.legrand@pasteur.fr.

background: plasmodium vivax malaria major public health problem french
guiana. cases resistance chloroquine, first-line treatment used
against p. vivax malaria, described brazilian amazon region. the
aim study investigate possible dispersion of
chloroquine-resistant p. vivax isolates french guiana. genotype,
polymorphism copy number variation, p. vivax multidrug resistance
gene-1 (pvmdr1) previously associated modification the
susceptibility chloroquine.
methods: pvmdr1 gene polymorphism evaluated sequencing copy number
variation assessed real-time pcr, p. vivax isolates obtained 591
symptomatic patients 1997 2013.
results: results reveal 1.0% [95% ci 0.4-2.2] french guiana isolates 
carry mutations y976f f1076l, proportion isolates with
multiple copies pvmdr1 significantly decreased time, 71.3%
(or = 6.2 [95% ci 62.9-78.7], p < 0.0001) 1997-2004 12.8% (or = 0.03 [95%
ci 9.4-16.9], p < 0.0001) 2009-2013. statistically significant relationship 
was found guf-a (harboring single mutation t958m) sal-1 (wild
type) alleles pvmdr1 copy number.
conclusions: p. vivax isolates harboring chloroquine-resistant mutations in
the pvmdr1 gene circulating french guiana. however, decrease the
prevalence isolates carrying multiple copies pvmdr1 might indicate the
p. vivax population french guiana evolving towards decreased
susceptibility chloroquine.

doi: 10.1186/s12936-016-1595-9 
pmcid: pmc5101641
pmid: 27825387  [indexed medline]

